Open Access
| Issue |
BIO Web Conf.
Volume 174, 2025
2025 7th International Conference on Biotechnology and Biomedicine (ICBB 2025)
|
|
|---|---|---|
| Article Number | 01024 | |
| Number of page(s) | 5 | |
| Section | Advances in Molecular Biology and Genetic Research | |
| DOI | https://doi.org/10.1051/bioconf/202517401024 | |
| Published online | 12 May 2025 | |
- Marmor, H. N., et al., Biomarkers in LC screening: a narrative review. Current Challenges in Thoracic Surgery, 2023. 5: p. 5-5. [CrossRef] [Google Scholar]
- Liu, Z., et al., Long non-coding RNA DINO promotes cisplatin sensitivity in lung adenocarcinoma via the p53-Bax axis. Journal of Thoracic Disease, 2023. 15(4): p. 2198-2212. [CrossRef] [Google Scholar]
- Li, P., et al., Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of LC. Clin Epigenetics, 2022. 14(1): p. 118. [CrossRef] [PubMed] [Google Scholar]
- Hong, Y. and W.J. Kim, DNA Methylation Markers in LC. Curr Genomics, 2021. 22(2): p. 79-87. [CrossRef] [Google Scholar]
- Duan, J., et al., DNA methylation in pulmonary fibrosis and LC. Expert Rev Respir Med, 2022. 16(5): p. 519-528. [CrossRef] [PubMed] [Google Scholar]
- Wrangle, J., et al., Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of LC. Clin Cancer Res, 2014. 20(7): p. 1856-64. [CrossRef] [PubMed] [Google Scholar]
- Lokk, K., et al., Methylation markers of early-stage non-small cell LC. PLoS One, 2012. 7(6): p. e39813. [CrossRef] [Google Scholar]
- Guo, S., et al., Identification and validation of the methylation biomarkers of non-small cell LC (NSCLC). Clinical Epigenetics, 2015. 7(1). [CrossRef] [PubMed] [Google Scholar]
- Oh, T. J., et al., Identification and validation of PCDHGA12 and PRRX1 methylation for detecting LC in bronchial washing sample. Oncology Letters, 2024. 27(6). [CrossRef] [PubMed] [Google Scholar]
- Ji, M., et al., Association of promoter methylation with histologic type and pleural indentation in non-small cell LC (NSCLC). Diagnostic Pathology, 2011. 6(1). [CrossRef] [Google Scholar]
- Rauch, T., et al., Homeobox gene methylation in LC studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A, 2007. 104(13): p. 5527-32. [CrossRef] [PubMed] [Google Scholar]
- Tessema, M., et al., Promoter methylation of genes in and around the candidate LC susceptibility locus 6q23-25. Cancer Res, 2008. 68(6): p. 1707-14. [CrossRef] [PubMed] [Google Scholar]
- Šutić, M., et al., Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell LC (NSCLC). Translational LC Research, 2019. 8(6): p. 1000-1015. [Google Scholar]
- Hu, S., et al., Accurate detection of early-stage LC using a panel of circulating cell-free DNA methylation biomarkers. Biomarker Research, 2023. 11(1). [CrossRef] [Google Scholar]
- Zhao, H., et al., A Sight of the Diagnostic Value of Aberrant Cell-Free DNA Methylation in LC. Disease Markers, 2022. 2022: p. 1-15. [Google Scholar]
- Qu, Y., et al., Blood FOLR3 methylation dysregulations and heterogeneity in non-small LC highlight its strong associations with lung squamous carcinoma. Respiratory Research, 2024. 25(1). [CrossRef] [Google Scholar]
- Qiao, R., et al., The Association Between RAPSN Methylation in Peripheral Blood and Early Stage LC Detected in Case-Control Cohort. Cancer Manag Res, 2020. 12: p. 11063-11075. [CrossRef] [Google Scholar]
- Wang, L., et al., Methylation Markers for Small Cell LC in Peripheral Blood Leukocyte DNA. Journal of Thoracic Oncology, 2010. 5(6): p. 778-785. [CrossRef] [Google Scholar]
- Wei, B., et al., A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of LC. Scientific Reports, 2021. 11(1). [Google Scholar]
- Yang, Z., et al., DNA methylation analysis of selected genes for the detection of early-stage LC using circulating cell-free DNA. Advances in Clinical and Experimental Medicine, 2018. 28(3): p. 355-360. [CrossRef] [Google Scholar]
- Kang, G., et al., Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical LC patients: protocol for a prospective observational study. BMC Cancer, 2019. 19(1). [Google Scholar]
- Du, C., et al., Detection of the DNA methylation of seven genes contribute to the early diagnosis of LC. Journal of Cancer Research and Clinical Oncology, 2024. 150(2). [CrossRef] [Google Scholar]
- Liang, W., et al., Non-invasive diagnosis of early-stage LC using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA). Theranostics, 2019. 9(7): p. 2056-2070. [CrossRef] [Google Scholar]
- Kang, C., et al., Construction and Validation of a LC Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers. Computational and Mathematical Methods in Medicine, 2021. 2021: p. 1-7. [CrossRef] [Google Scholar]
- Liu, B., et al., Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell LC. Clinical Cancer Research, 2020. 26(16): p. 4339-4348. [CrossRef] [PubMed] [Google Scholar]
- Guzmán, L., et al., Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and LC in smokers. Diagn Pathol, 2012. 7: p. 87. [CrossRef] [Google Scholar]
- Leng, S., et al., Gene methylation biomarkers in sputum as a classifier for LC risk. Oncotarget, 2017. 8(38): p. 63978-63985. [CrossRef] [Google Scholar]
- Soukiasian, H. J., et al., Highly sensitive noninvasive early LC detection using DNA methylation topology in sputum-derived epithelial cells. JTCVS Open, 2023. 13: p. 389-410. [CrossRef] [Google Scholar]
- Shin, K.-C., et al., MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with LC and non-malignant lung diseases. Oncology Reports, 2012. 27(4): p. 911-916. [CrossRef] [PubMed] [Google Scholar]
- Wielscher, M., et al., Diagnostic Performance of Plasma DNA Methylation Profiles in LC, Pulmonary Fibrosis and COPD. EBioMedicine, 2015. 2(8): p. 929-936. [CrossRef] [PubMed] [Google Scholar]
- Shames, D. S., et al., A genome-wide screen for promoter methylation in LC identifies novel methylation markers for multiple malignancies. PLoS Med, 2006. 3(12): p. e486. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.